Anti-CD38/CD3 T cell-redirecting bispecific antibody (Sorrento Therapeutics)

N/A

ๆŠฅๅ‘Šๆ—ถ้—ด: 2026/03/24 20:00:35

ๅŸบๆœฌไฟกๆฏ

่ฏ็‰ฉๅ็งฐAnti-CD38/CD3 T cell-redirecting bispecific antibody (Sorrento Therapeutics)
่ฏ็‰ฉๅˆซ็งฐanti-CD38/CD3 bispecific antibody (Sorrento Therapeutics)anti-CD3/anti-CD38 bispecific T-cell engager (Sorrento Therapeutics)
่ฏ็‰ฉ็ฑปๅž‹็”Ÿ็‰ฉ่ฏ > ่›‹็™ฝ็ฑป่ฏ็‰ฉ > ๅ…็–ซ็ƒ่›‹็™ฝ > ๆŠ—ไฝ“ > ๅ•ๅ…‹้š†ๆŠ—ไฝ“ > ๅคš็‰นๅผ‚ๆ€งๅ•ๅ…‹้š†ๆŠ—ไฝ“ > ๅŒ็‰นๅผ‚ๆ€งๆŠ—ไฝ“็”Ÿ็‰ฉ่ฏ > T็ป†่ƒžๆŽฅๅˆๅ™จ็”Ÿ็‰ฉ่ฏ > ่›‹็™ฝ็ฑป่ฏ็‰ฉ > ๅ…็–ซ็ƒ่›‹็™ฝ > ๆŠ—ไฝ“ > ๅ•ๅ…‹้š†ๆŠ—ไฝ“ > ไบบๆบๅŒ–ๅ•ๅ…‹้š†ๆŠ—ไฝ“
ไฝœ็”จๆœบๅˆถๆŠ—CD38CD3 T็ป†่ƒžๅ‹Ÿ้›†ๅ‰‚
้ถ็‚นๆท‹ๅทด็ป†่ƒžๅˆ†ๅŒ–ๆŠ—ๅŽŸCD38T็ป†่ƒž่กจ้ข็ณ–่›‹็™ฝCD3ๅคๅˆไฝ“
ๆฒป็–—้ข†ๅŸŸ / ้€‚ๅบ”็—‡ๅคšๅ‘ๆ€ง้ชจ้ซ“็˜ค
ๅ…จ็ƒๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
ไธญๅ›ฝๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
้ฆ–ๆ‰นๅ›ฝๅฎถ/ๅŒบๅŸŸN/A
้ฆ–ๆ‰นๆ—ฅๆœŸN/A
ๅ›ฝๅฎถ/ๅŒบๅŸŸ็พŽๅ›ฝ
ๆ˜ฏๅฆๅคๆ–นๅฆ
ๅ…จ็ƒๆœ€้ซ˜็ ”ๅ‘็Šถๆ€ๆ— ่ฟ›ๅฑ• (ไธดๅบŠๅ‰)
ไธญๅ›ฝๆœ€้ซ˜็ ”ๅ‘็Šถๆ€N/A
ๅŽŸ็ ”ๅ…ฌๅธSorrento Therapeutics Inc
ๆณจๅ†Œๅˆ†็ฑปN/A

็ ”ๅ‘ไฟกๆฏ

ๆดป่ทƒๅ…ฌๅธN/A
้žๆดป่ทƒๅ…ฌๅธSorrento Therapeutics Inc
ๆดป่ทƒ้€‚ๅบ”็—‡N/A
้žๆดป่ทƒ้€‚ๅบ”็—‡ๅคšๅ‘ๆ€ง้ชจ้ซ“็˜ค

ๅ…ถไป–ไฟกๆฏ

ATCไปฃ็ N/A
็›ธๅ…ณ้“พๆŽฅN/A